research use only
Cat.No.S6719
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| HEK293 | Function assay | 24 hrs | Antagonist activity at human TLR9 expressed in HEK293 cells assessed as inhibition of CpGB-induced NF-kappaB activation after 24 hrs by spectrophotometry based SEAP reporter gene assay, IC50=0.015μM | 28437629 | ||
| plasmacytoid dendritic cells | Function assay | 18 hrs | Antagonist activity at TLR9 in human plasmacytoid dendritic cells assessed as inhibition of CpGA-induced IFN-alpha production after 18 hrs by ELISA, IC50<0.05μM | 28437629 | ||
| HEK293 | Function assay | 24 hrs | Antagonist activity at human TLR7 expressed in HEK293 cells assessed as inhibition of CL264-induced NF-kappaB activation after 24 hrs by spectrophotometry based SEAP reporter gene assay, IC50=1.99μM | 28437629 | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
Water : 100 mg/mL
DMSO
: 3 mg/mL
(5.74 mM)
Ethanol : 2 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 522.51 | Formula | C27H37Cl2N3O3 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 1345675-25-3 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1CCN(C1)CCCOC2=CC=C(C=C2)C3=NC4=C(O3)C=C(C=C4)OCCCN5CCCC5.Cl.Cl | ||
| Targets/IC50/Ki |
TLR9
|
|---|---|
| In vivo |
E6446 is orally bioavailable (20%) and has high volumes of distribution in mice (95.9 l/kg). |
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.